Safety, pharmacokinetics and pharmacodynamics of recombinant human tumour necrosis factor-binding protein-1 (Onercept) injected by intravenous, intramuscular and subcutaneous routes into healthy volunteers.

Saved in:
Bibliographic Details
Title: Safety, pharmacokinetics and pharmacodynamics of recombinant human tumour necrosis factor-binding protein-1 (Onercept) injected by intravenous, intramuscular and subcutaneous routes into healthy volunteers.
Authors: Trinchard-Lugan I; Serono International SA, 12, chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland., Ho-Nguyen Q, Bilham WM, Buraglio M, Ythier A, Munafo A
Source: European cytokine network [Eur Cytokine Netw] 2001 Jul-Sep; Vol. 12 (3), pp. 391-8.
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: John Libbey Eurotext Ltd Country of Publication: France NLM ID: 9100879 Publication Model: Print Cited Medium: Print ISSN: 1148-5493 (Print) Linking ISSN: 11485493 NLM ISO Abbreviation: Eur Cytokine Netw Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1148-5493